GSK and RB desert Pfizer
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
GlaxoSmithKline (GSK) and Reckitt Benckiser (RB) have pulled out of the race to acquire Pfizer Consumer Healthcare, with both firms separately confirming that they had ended talks with the US pharmaceuticals giant.
You may also be interested in...
Reckitt Begins CEO Search As Kapoor Departs The Company He Reshaped
Reckitt Benckiser's long-serving CEO, Rakesh Kapoor, has unexpectedly announced his intention to retire by the end of the year, with the company immediately kicking off the search for his replacement. Kapoor will be remembered for transforming RB's consumer health business, but also for a number of setbacks under his watch which have impacted results.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.